Unbound MEDLINE

Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants. International journal of oncology. [Int J Oncol] Journal article

 
TitleResveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants.
Author(s)Ulsperger E, Hamilton G, Raderer M, Baumgartner G, Hejna M, Hoffmann O, Mallinger R 
InstitutionLudwig Boltzmann Institute of Clinical Oncology, KH Lainz, Austria.
SourceInt J Oncol 1999 Nov; 15(5):955-9.
MeSHAlkaline Phosphatase
Antineoplastic Agents, Phytogenic
Breast Neoplasms
Carcinoma, Renal Cell
Cell Differentiation
Cell Line
Culture Media, Conditioned
Estrogens, Non-Steroidal
Female
Humans
Isoflavones
Kidney Neoplasms
Lung
Male
Osteoblasts
Pancreatic Neoplasms
Phytoestrogens
Plant Preparations
Prostatic Neoplasms
Research Support, Non-U.S. Gov't
Stilbenes
Tamoxifen
Tumor Cells, Cultured
AbstractResveratrol, a natural phytoestrogen, has been reported to promote differentiation of murine MC3T3-E1 osteoblasts and to inhibit proliferation of prostate cancer cell lines. In the present study we tested the effects of resveratrol on the increased proliferation of human AHTO-7 osteoblastic cell line induced by conditioned media (CM) from a panel of carcinoma cell lines. This compound was found to modulate AHTO-7 proliferation in a tamoxifen-sensitive mechanism at lower concentrations, but failed to induce the osteoblast differentiation marker alkaline phosphatase (ALP) in contrast to vitamin D3. The proliferative response of AHTO-7 cells to conditioned media from carcinoma cell lines was diminished (30-71.4% inhibition) upon pretreatment with 0.5 microM resveratrol. Highest inhibition was demonstrated for pancreas (BxPC3, Panc-1), breast (ZR75-1) and renal (ACHN) carcinoma cell line supernatants whereas the effect on colon carcinoma (SW620, Colo320DM) cell CM and prostate cancer (PC3, DU145 and LNCaP) CM was less pronounced. Direct addition of resveratrol affected only supernatants of cell lines (<25% inhibition) exhibiting growth stimulatory activity for normal WI-38 lung fibroblasts. Resveratrol inhibited proliferation of DU145 and LNCaP cells in concentrations exceeding 5 microM, altered cell cycle distribution of all prostate cancer cell lines in concentrations as low as 0.5 microM, but did not inhibit the production of osteoblastic factors by these lines. In conclusion, resveratrol failed to induce ALP activity as marker of osteoblast differentiation in human osteoblastic AHTO-7 cells, however, inhibited their response to osteoblastic carcinoma-derived growth factors in concentrations significantly lower than those to reduce growth of cancer cells, thus effectively modulating tumor - osteoblast interaction.
Languageeng
Pub Type(s)Journal Article
PubMed ID10536179
  
Advertise on this site.